A putative three-dimensional arrangement of the human serotonin transporter transmembrane helices: a tool to aid experimental studies.

The human serotonin transporter is the molecular target for selective serotonin reuptake inhibitor drugs which are being used for treatment of depression. A three-dimensional model of the membrane spanning parts of the transporter was constructed. The transporter was assumed to consist of 12 transmembrane alpha-helices. The model was based on published experimental data of cocaine binding to mutant transporters, amino acid sequence analysis, and interactive molecular graphics. The model suggests that a high affinity cocaine binding site is situated in a region of the model where Asp98 acts like an anchor, while a putative low affinity site is situated in another region with Glu508 as the anchoring amino acid. A series of docking experiments with various reuptake inhibitors were conducted, using interactive molecular graphics techniques combined with energy calculations and analysis of the transporter-ligand complexes. Experiments involving molecular mapping of ligand binding areas may benefit from using the current model in experimental design. From the current model, several amino acids were proposed as prime candidates for mutagenesis and subsequent ligand binding studies. Also for evaluation of results from site directed mutagenesis experiments with SERT and similar transporters we assume the model will be helpful.

[1]  G. Uhl,et al.  Sodium- and chloride-dependent transporters in brain, kidney, and gut: lessons from complementary DNA cloning and structure-function studies. , 1993, Current opinion in nephrology and hypertension.

[2]  H. Betz,et al.  A single serine residue controls the cation dependence of substrate transport by the rat serotonin transporter. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Blakely,et al.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.

[4]  T. Dohi,et al.  Cellular and molecular aspects of monoamine neurotransmitter transporters. , 1996, Japanese journal of pharmacology.

[5]  R. Blakely,et al.  High Affinity Recognition of Serotonin Transporter Antagonists Defined by Species-scanning Mutagenesis , 1998, The Journal of Biological Chemistry.

[6]  A Elofsson,et al.  Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. , 1997, Protein engineering.

[7]  D. Dwyer,et al.  Model of the 3‐D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport , 2001, Proteins.

[8]  Jing Chen,et al.  Determination of External Loop Topology in the Serotonin Transporter by Site-directed Chemical Labeling* , 1998, The Journal of Biological Chemistry.

[9]  W. Soudijn,et al.  5-HT transporter , 1997 .

[10]  M. Saier,et al.  A functional superfamily of sodium/solute symporters. , 1994, Biochimica et biophysica acta.

[11]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[12]  J. Callaway,et al.  Ligand interaction with the purified serotonin transporter in solution and at the air/water interface , 2000, FEBS letters.

[13]  S Kitayama,et al.  Tyrosine-533 of rat dopamine transporter: involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine. , 1998, Brain research. Molecular brain research.

[14]  Peter A. Kollman,et al.  Structural changes by sulfoxidation of phenothiazine drugs , 1992, J. Comput. Aided Mol. Des..

[15]  G. Rudnick,et al.  Critical Amino Acid Residues in Transmembrane Span 7 of the Serotonin Transporter Identified by Random Mutagenesis* , 1998, The Journal of Biological Chemistry.

[16]  H. Sitte,et al.  Oligomerization of the Human Serotonin Transporter and of the Rat GABA Transporter 1 Visualized by Fluorescence Resonance Energy Transfer Microscopy in Living Cells* , 2001, The Journal of Biological Chemistry.

[17]  F I Carroll,et al.  Biophysical Characterization of the Cocaine Binding Pocket in the Serotonin Transporter Using a Fluorescent Cocaine Analogue as a Molecular Reporter* , 2001, The Journal of Biological Chemistry.

[18]  S Kitayama,et al.  Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Giménez,et al.  Analysis of the Transmembrane Topology of the Glycine Transporter GLYT1* , 1997, The Journal of Biological Chemistry.

[20]  A. Bendahan,et al.  Only one of the charged amino acids located in the transmembrane alpha-helices of the gamma-aminobutyric acid transporter (subtype A) is essential for its activity. , 1993, The Journal of biological chemistry.

[21]  G. Uhl,et al.  Dopamine transporter mutants selectively enhance MPP+ transport , 1993, Synapse.

[22]  Øyvind Edvardsen,et al.  A World Wide Web-service to Aid the Development of AMBER Parameters using Analogy to Standard Parameters , 1999, Comput. Chem..

[23]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[24]  G. Rudnick,et al.  The Role of External Loop Regions in Serotonin Transport , 1999, The Journal of Biological Chemistry.

[25]  S. Dahl,et al.  A putative model of the dopamine transporter. , 1994, Brain research. Molecular brain research.

[26]  P. Kollman,et al.  Application of RESP charges to calculate conformational energies, hydrogen bond energies, and free energies of solvation , 1993 .

[27]  G. Rudnick,et al.  Permeation and gating residues in serotonin transporter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K. Williams,et al.  Three-dimensional structure of the ion-coupled transport protein NhaA , 2000, Nature.

[29]  U. Singh,et al.  A NEW FORCE FIELD FOR MOLECULAR MECHANICAL SIMULATION OF NUCLEIC ACIDS AND PROTEINS , 1984 .

[30]  D. Wong,et al.  Effects of antidepressants on uptake and receptor systems in the brain , 1985, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[31]  G. Uhl,et al.  Expression of a single dopamine transporter cDNA can confer two cocaine binding sites , 1992, Neuroreport.

[32]  Rolf Apweiler,et al.  The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000 , 2000, Nucleic Acids Res..

[33]  Conrad C. Huang,et al.  The MIDAS display system , 1988 .

[34]  N. Connell,et al.  A Peptide Permease Mutant of Mycobacterium bovis BCG Resistant to the Toxic Peptides Glutathione andS-Nitrosoglutathione , 2000, Infection and Immunity.

[35]  H. Kaback,et al.  From membrane to molecule to the third amino acid from the left with a membrane transport protein , 1997, Quarterly Reviews of Biophysics.

[36]  B. Kanner,et al.  The Membrane Topology of GAT-1, a (Na+ + Cl−)-coupled γ-Aminobutyric Acid Transporter from Rat Brain* , 1997, The Journal of Biological Chemistry.

[37]  C. Jung,et al.  Proposed structure of putative glucose channel in GLUT1 facilitative glucose transporter. , 1996, Biophysical journal.

[38]  B. Kanner,et al.  Identification of tryptophan residues critical for the function and targeting of the gamma-aminobutyric acid transporter (subtype A). , 1994, The Journal of biological chemistry.

[39]  Eric L. Barker,et al.  Transmembrane Domain I Contributes to the Permeation Pathway for Serotonin and Ions in the Serotonin Transporter , 1999, The Journal of Neuroscience.

[40]  G. Rudnick,et al.  The Third Transmembrane Domain of the Serotonin Transporter Contains Residues Associated with Substrate and Cocaine Binding* , 1997, The Journal of Biological Chemistry.

[41]  Henry A. Lester,et al.  Topological localization of cysteine 74 in the GABA transporter, GAT1, and its importance in ion binding and permeation , 1998, FEBS letters.

[42]  Olga Kennard,et al.  Systematic analysis of structural data as a research technique in organic chemistry , 1983 .

[43]  A. S. Chang,et al.  Possible existence of quaternary structure in the high-affinity serotonin transport complex. , 1998, Biochemical and biophysical research communications.

[44]  G. Heijne Membrane protein structure prediction. Hydrophobicity analysis and the positive-inside rule. , 1992, Journal of molecular biology.

[45]  G. Tusnády,et al.  Principles governing amino acid composition of integral membrane proteins: application to topology prediction. , 1998, Journal of molecular biology.

[46]  B. Rost PHD: predicting one-dimensional protein structure by profile-based neural networks. , 1996, Methods in enzymology.

[47]  J. Hyttel Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) , 1994, International clinical psychopharmacology.

[48]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[49]  H. Betz,et al.  Distinct Effects of Imipramine on 5‐Hydroxytryptamine Uptake Mediated by the Recombinant Rat Serotonin Transporter SERT1 , 1998, Journal of neurochemistry.

[50]  S Kitayama,et al.  Dissection of Dopamine and Cocaine Binding Sites on the Rat Dopamine Transporter Expressed in COS Cells a , 1996, Annals of the New York Academy of Sciences.

[51]  Erik L. L. Sonnhammer,et al.  A Hidden Markov Model for Predicting Transmembrane Helices in Protein Sequences , 1998, ISMB.

[52]  R. Blakely,et al.  Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter. , 1996, Molecular pharmacology.

[53]  G. Rudnick,et al.  Functional Role of Critical Stripe Residues in Transmembrane Span 7 of the Serotonin Transporter , 2001, The Journal of Biological Chemistry.

[54]  T. Schwartz,et al.  Conversion of antagonist-binding site to metal-ion site in the tachykinin NK-1 receptor , 1995, Nature.

[55]  Øyvind Edvardsen A World-wide Web Service for Calculating Approximate Amber C-C and C-N Bond Stretching and Torsional Parameters , 1996, Comput. Chem..

[56]  D. Williams,et al.  The serotonin transporter: a primary target for antidepressant drugs , 1998, Journal of psychopharmacology.